Search research articles
Contact Us
Filters
Showing results (211-220 of 262) with videos related to
Page
of 27
Sort By:
Clinical and Experimental Rheumatology
|
February 28, 2022
Defining anti-synthetase syndrome: a systematic literature review
Giovanni Zanframundo, Sara Faghihi-Kashani, Carlo Alberto Scirè, et al.
Rheumatology International
|
November 15, 2021
COVID-19 vaccination in autoimmune disease (COVAD) survey protocol
Parikshit Sen, Latika Gupta, James B Lilleker, et al.
Annals of the Rheumatic Diseases
|
August 25, 2022
Coexisting autoantibodies against transcription factor Sp4 are associated with decreased cancer risk in patients with dermatomyositis with anti-TIF1γ autoantibodies
Yuji Hosono, Brandon Sie, Iago Pinal-Fernandez, et al.
Clinical and Experimental Rheumatology
|
February 20, 2025
The Myositis Clinical Trials Consortium: an international collaborative initiative to promote clinical trials in adult and juvenile myositis
Anuradha Bishnoi, Iris Yan Ki Tang, Akira Yoshida, et al.
Journal of Clinical Medicine
|
December 23, 2023
COVID-19 Vaccination-Related Delayed Adverse Events among Patients with Systemic Lupus Erythematosus
Mrinalini Dey, Bohdana Doskaliuk, Julius Lindblom, et al.
Rheumatology (Oxford, England)
|
June 17, 2022
COVID-19 vaccination-related adverse events among autoimmune disease patients: results from the COVAD study
Parikshit Sen, Naveen Ravichandran, Arvind Nune, et al.
Seminars in Arthritis and Rheumatism
|
November 2, 2025
Analytical performance of commercial myositis-specific autoantibody tests evaluated against immunoprecipitation assays as a reference standard: A systematic review and meta-analysis
Takahisa Gono, Albert Gil-Vila, Albert Selva-O'Callaghan, et al.
Rheumatology (Oxford, England)
|
November 22, 2022
Safety and tolerance of vaccines against SARS-CoV-2 infection in systemic lupus erythematosus: results from the COVAD study
R Naveen, Elena Nikiphorou, Mrudula Joshi, et al.
Lancet (London, England)
|
January 11, 2025
Efficacy, safety, and target engagement of dazukibart, an IFNβ specific monoclonal antibody, in adults with dermatomyositis: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial
David Fiorentino, Aaron R Mangold, Victoria P Werth, et al.
The New England Journal of Medicine
|
October 5, 2022
Trial of Intravenous Immune Globulin in Dermatomyositis
Rohit Aggarwal, Christina Charles-Schoeman, Joachim Schessl, et al.
Page
of 27
Search research articles
Search
Showing results (211-220 of 262) with videos related to
Sort By:
Page
of 27
Clinical and Experimental Rheumatology
|
February 28, 2022
Defining anti-synthetase syndrome: a systematic literature review
Giovanni Zanframundo, Sara Faghihi-Kashani, Carlo Alberto Scirè, et al.
Rheumatology International
|
November 15, 2021
COVID-19 vaccination in autoimmune disease (COVAD) survey protocol
Parikshit Sen, Latika Gupta, James B Lilleker, et al.
Annals of the Rheumatic Diseases
|
August 25, 2022
Coexisting autoantibodies against transcription factor Sp4 are associated with decreased cancer risk in patients with dermatomyositis with anti-TIF1γ autoantibodies
Yuji Hosono, Brandon Sie, Iago Pinal-Fernandez, et al.
Clinical and Experimental Rheumatology
|
February 20, 2025
The Myositis Clinical Trials Consortium: an international collaborative initiative to promote clinical trials in adult and juvenile myositis
Anuradha Bishnoi, Iris Yan Ki Tang, Akira Yoshida, et al.
Journal of Clinical Medicine
|
December 23, 2023
COVID-19 Vaccination-Related Delayed Adverse Events among Patients with Systemic Lupus Erythematosus
Mrinalini Dey, Bohdana Doskaliuk, Julius Lindblom, et al.
Rheumatology (Oxford, England)
|
June 17, 2022
COVID-19 vaccination-related adverse events among autoimmune disease patients: results from the COVAD study
Parikshit Sen, Naveen Ravichandran, Arvind Nune, et al.
Seminars in Arthritis and Rheumatism
|
November 2, 2025
Analytical performance of commercial myositis-specific autoantibody tests evaluated against immunoprecipitation assays as a reference standard: A systematic review and meta-analysis
Takahisa Gono, Albert Gil-Vila, Albert Selva-O'Callaghan, et al.
Rheumatology (Oxford, England)
|
November 22, 2022
Safety and tolerance of vaccines against SARS-CoV-2 infection in systemic lupus erythematosus: results from the COVAD study
R Naveen, Elena Nikiphorou, Mrudula Joshi, et al.
Lancet (London, England)
|
January 11, 2025
Efficacy, safety, and target engagement of dazukibart, an IFNβ specific monoclonal antibody, in adults with dermatomyositis: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial
David Fiorentino, Aaron R Mangold, Victoria P Werth, et al.
The New England Journal of Medicine
|
October 5, 2022
Trial of Intravenous Immune Globulin in Dermatomyositis
Rohit Aggarwal, Christina Charles-Schoeman, Joachim Schessl, et al.
Page
of 27